Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD10 and CD34 as markers in vascular malformations with PIK3CA and TEK mutations.

Human pathology - 1 May 2020

Moneghini Laura, Tosi Delfina, Graziani Daniela, Caretti Anna, Colletti Giacomo, Baraldini Vittoria, Cattaneo Elisa, Spaccini Luigina, Zocca Alfredo, Bulfamante Gaetano Pietro

Abstract excerpt

AIMS: Vascular malformations (vMs) encompass a wide range of diseases often associated with somatic or, more rarely, germinal genetic mutations. A mutation in the PIK3Ca/mTOR pathway is more often involved in various vMs. CD10 and CD34 are cellular markers that may play a role in mesenchymal differentiation and proliferation. The aim of our study was to find a possible link between the immunohistochemical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD34
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Class I Phosphatidylinositol 3-Kinases

Share to Endothelial Cells

Share to Immunohistochemistry

Share to Neprilysin

Share to Receptor, TIE-2

Share to Vascular Malformations

Source

Identifiers

PMID: 32272124
DOI: 10.1016/j.humpath.2020.04.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD10 and CD34 as markers in vascular malformations with PIK3CA and TEK mutations.PMID 32272124Read ↗

Comprehensive phenotypic and genomic characterization of venous malformations.Semantic proximity Read ↗

Comprehensive molecular and clinicopathological analysis of vascular malformations: A study of 319 casesSemantic proximity Read ↗

Somatic Activating PIK3CA Mutations Cause Venous Malformation.Semantic proximity Read ↗

Emerging importance of molecular pathogenesis of vascular malformations in clinical practice and classifications.Semantic proximity Read ↗

Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity.Semantic proximity Read ↗

Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.Semantic proximity Read ↗

Functional assessment of two variants of unknown significance in TEK by endothelium-specific expression in zebrafish embryos.Semantic proximity Read ↗

Angiopoietin–TIE2 feedforward circuit promotes PIK3CA-driven venous malformationsSemantic proximity Read ↗

TEK-related venous malformation of the orofacial region: report of a case with multidisciplinary treatment guided by molecular diagnosis.Semantic proximity Read ↗

Comprehensive Analysis of TEK Variants in Patients With Vascular Malformations.Semantic proximity Read ↗

Somatic PIK3CA mutations as a driver of sporadic venous malformations.Semantic proximity Read ↗

PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.